by David Randall | Oct 1, 2024 | RSS
For Immediate Release: September 26, 2024 Español Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat...
by David Randall | Oct 1, 2024 | RSS
[embedded content] Español 中文 한국의 Tagalog Tiếng Việt Is It Really “FDA Approved”? Part 2. Here are 10 more facts about how the FDA works to protect public health. Fact #11: The FDA regulates dermal fillers as medical devices. Dermal fillers are gel-like...